Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Lorin K, Johnson"'
Publikováno v:
The American Journal of Gastroenterology. 98:216-219
Treatment of Ulcerative Colitis With Balsalazide: Response to Editorial by Drs. Farrell and Peppercorn and Letter to the Editor by Dr. Hanauer
Autor:
Ronald Pruitt, David Sales, George Koval, John K Bell, Dennis Riff, Lawrence Wruble, Lorin K Johnson, Douglas S. Levine
Publikováno v:
The American Journal of Gastroenterology. 97:1398-1407
A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis
Publikováno v:
European Journal of Biochemistry. 227:116-122
Urokinase plasminogen activator receptor (uPAR) gene expression has been implicated in many important biological processes including cell invasiveness and migration. The uPAR gene was cloned from a human genomic library by hybridization with a uPAR c
Autor:
Young S. Kim, Vivian Weinberg, Kenneth R. McQuaid, Lorin K. Johnson, James R. Gum, Marvin H. Sleisenger, Jonathan P. Terdiman, Ann Hayes
Publikováno v:
Digestive diseases and sciences, vol 54, iss 11
Terdiman, Jonathan P.; Johnson, Lorin K.; Kim, Young S.; Sleisenger, Marvin H.; Gum, James R.; Hayes, Ann; et al.(2009). Chemoprevention of Colonic Polyps with Balsalazide: An Exploratory, Double-Blind, Placebo-Controlled Study. Digestive Diseases and Sciences, 54(11), pp 2488-2496. doi: 10.1007/s10620-009-0966-2. Retrieved from: http://www.escholarship.org/uc/item/2362017j
Digestive Diseases and Sciences
Terdiman, Jonathan P.; Johnson, Lorin K.; Kim, Young S.; Sleisenger, Marvin H.; Gum, James R.; Hayes, Ann; et al.(2009). Chemoprevention of Colonic Polyps with Balsalazide: An Exploratory, Double-Blind, Placebo-Controlled Study. Digestive Diseases and Sciences, 54(11), pp 2488-2496. doi: 10.1007/s10620-009-0966-2. Retrieved from: http://www.escholarship.org/uc/item/2362017j
Digestive Diseases and Sciences
Backgroud A number of agents, including aspirin, nonsteroidal antiinflammatory drugs, cyclooxygenase-2 inhibitors, folic acid, calcium, and vitamins, have been evaluated for their potential in chemoprevention of sporadic colorectal adenomas or cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04c98e9d3ec986934b459377208ed2eb
https://escholarship.org/uc/item/71b918rh
https://escholarship.org/uc/item/71b918rh
Autor:
Jeff Seilhamer, Amanda E. Goodman, Marion Loughnan, Danielle Cairns, Lorin K. Johnson, Richard Buchta, Adam S. Inglis, Albert Tseng, Kieran F. Scott
Publikováno v:
Protein Expression and Purification. 2:127-135
An active preparation of human phospholipase A2 (PLA2) was made after expression as an insoluble fusion protein in Escherichia coli. The new key elements required for PLA2 isolation were the maintenance of the fusion protein in solution after the ini
Autor:
Lorin K. Johnson, Ira Shafran
Publikováno v:
Current medical research and opinion. 21(8)
This open-label study was conducted as a preliminary assessment of rifaximin (200 mg TID for 16 weeks) for the treatment of active Crohn's disease in patients (n = 29) with symptoms for at least 3 months before screening and a Crohn's Disease Activit
Autor:
Michael Safdi, John S. Hanson, Pamela Doty, Lorin K. Johnson, George Koval, John Johanson, Amanda Cross, Ronald Pruitt, Robert Hardi, Barry Winston, Lawrence Wruble, Dennis Riff
Publikováno v:
The American journal of gastroenterology. 97(12)
Balsalazide is a novel azo-bonded 5-aminosalicylic acid treatment for mild-to-moderate ulcerative colitis. The study objective was to compare symptomatic remission rates with balsalazide and mesalamine while controlling for extent of disease and time
Autor:
Douglas S, Levine, Dennis S, Riff, Ronald, Pruitt, Lawrence, Wruble, George, Koval, David, Sales, John K, Bell, Lorin K, Johnson
Publikováno v:
The American journal of gastroenterology. 97(6)
Balsalazide is a new innovative, mesalamine-containing prodrug that is activated by bacteria in the colon. Balsalazide has been shown previously to be well tolerated and effective in the treatment of acute ulcerative colitis. The aim of this study wa
Autor:
Howard Curtis, Clare T. Atherton, W. A. Stack, Nick J. Wight, John Jones, Lorin K. Johnson, Pamela Doty, Christopher J. Hawkey, Shri Pathmakanthan
Publikováno v:
Gastroenterology. 118:A1224-A1225
Autor:
Amanda J. Cross, John F. Johanson, John S. Hanson, Dennis Riff, Pamela Doty, Ronald E. Pruitt, Lawrence Wruble, Michael Safdi, George Koval, Robert Hardi, Lorin K. Johnson, Barry Winston
Publikováno v:
Gastroenterology. 118:A120-A121